Summary: Thailand’s largest stem cell bank, Medeze Group, has offered to acquire a 10% stake in Singapore-listed cord blood bank Cordlife Group. The offer, valued at 25.63 million shares at 25 cents each, represents a 61.3% premium over Cordlife’s last traded price. If successful, Medeze aims to explore long-term business opportunities with Cordlife, leveraging their complementary services.

Link: https://www.straitstimes.com/business/companies-markets/cordlife-gets-offer-from-thailands-largest-stem-cell-bank-medeze-group-for-10-stake-in-company